Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 11:42 AM. | Search:

» StockRants Stock Forum » Public Stock Forums » Canadian Stock Picks » Strong Buy: CPH.T (MC $39 M) Profitable Biotech / 2x Big Drug approvals this year



Reply
 
Thread Tools Search this Thread
Old 03-22-2019, 11:45 AM   Nav to Top  #1
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Default CPH.T (MC $39 M) Profitable Biotech / 2x Big Drug approvals this year

Undiscovered and Profitable Biotech with significant upside potential ..Many new attractive Product launches and approvals expected within this year .Tgt $10+


Cipher Pharmaceuticals (CPH.T)

Market Cap: $39.7 Million CAD
Cash $10.4 Million CAD
Price: $1.46

Shares Out: 26.8 Million


Slide Presentation
https://filecache.investorroom.com/m...19%20Final.pdf


Cipher anticipates several key milestones in 2019 that will continue to enhance long term value, including:

Xydalba launch in first half of 2019

DTR-001 pre-clinical results in Q2 2019

Regulatory approval for plecanatide from Health Canada in Q4 2019

Regulatory approval for A-101 from Health Canada in Q4 2019

Top line results for MOB-015 Phase 3 study in North America expected in late Q4 2019


Largest Shareholder :

John Douglas Mull, MD 9,911,265
Grandeur Peak Global Advisors LLC 1,522,200
Taylor Asset Management, Inc. (Canada) 243,100
Harold Morton Wolkin, CFA 184,134
Arthur M. Deboeck 104,300
Mark A. Beaudet 87,790
Christian Godin 39,009
Robert D. Tessarolo 37,013
Stephen L. Lemieux, CPA 25,008
Acadian Asset Management LLC 9,093


Biohero is offline   Rate this post Yes | No Reply With Quote
Old 03-22-2019, 02:04 PM   Nav to Top  #2
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Loe gives a 12-month return of 257 per cent for the stock, saying the specialty pharma company’s pipeline prospects are encouraging.
https://www.cantechletter.com/2019/0...chelon-wealth/
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 09-04-2019, 09:39 AM   Nav to Top  #3
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Strong insider buying in last days and many big milestones coming before year end ..Great buying opportunity here

https://www.canadianinsider.com/node...harmaceuticals

Cipher anticipates several key milestones in 2019 that will continue the growth of its Canadian commercial platform, including:

*Regulatory approval for plecanatide from Health Canada in Q4 2019

*Regulatory approval for A-101 from Health Canada in Q4 2019

*Commercial launch of XYDALBA (dalbavancin)

*North American top line results for MOB-015 in Q4 2019
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 09-06-2019, 09:37 AM   Nav to Top  #4
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Both attractive drugs below could be approved by health canada within next month which could push this low float stock significantly higher ...


Cipher Pharmaceuticals Announces A-101 40% Topical Solution Accepted for Review by Health Canada....Dec. 18, 2018
https://cipher.investorroom.com/2018...-Health-Canada


Cipher Pharmaceuticals Announces PLECANATIDE Accepted for Review by Health Canada....Dec. 17, 2018
https://cipher.investorroom.com/2018...-Health-Canada
Biohero is offline   Rate this post Yes | No Reply With Quote
Old Today, 09:32 AM   Nav to Top  #5
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

3-4 Weeks then drug approvals likely to come in .. this low float stock could double quickly.GL

Biohero is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Buy: See It: Biotech ETF Chart Predicted Trump Would Trash The Biotech/Pharma Stocks AnnabelleTrader US Stock Picks 0 01-11-2017 04:42 PM
Strong Buy: IGXT (Mcap $31 M) 1x Drug launched + 2x NDA filings in 1Q13 + Profitable in 2013 Biohero US Penny Stock Picks 0 12-30-2012 07:57 PM
Strong Buy: IGXT (Mcap $29 M) 1x Drug launched + 2x NDA filings in 1Q13 + Profitable in 2013 Biohero US Penny Stock Picks 0 12-27-2012 07:34 AM
Watch: SPAR Group Reports 53% Increase in Second Quarter, Year-Over-Year Revenue to $24.3 Mi micro2midcapper US Penny Stock Picks 0 08-07-2012 10:57 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On